Suppr超能文献

细胞学实验室是否应对巴氏试验检测子宫内膜癌的低敏感性负责?

Does Cytological Laboratory Holds the Responsibility for the Low Sensitivity of the PAP Test in Detecting Endometrial Cancer?

作者信息

Milicić Valerija, Matić Tereza Solocki, Martinek Vjenceslav, Tomasković Igor, Ramljak Vesna

出版信息

Coll Antropol. 2015 Sep;39(3):713-7.

Abstract

Endometrial cancer is the most common gynecological cancer but there is no economically justified screening method. Although we can detect endometrial cells in the sample using PAP test, many studies show low sensitivity and positive predictive value of PAP test for the diagnosis of endometrial cancer. The goal of this research was to determine significance of PAP test for the diagnostics of endometrial carcinoma. Sensitivity and specificity were analyzed with statistical parameters. VCE (vaginal, cervical, endocervical) smears of patients with histologically proven endometrial carcinoma were re-examined in order to determine the proportion of false negative results for endometrial cancer cells in the VCE samples. Study group consisted of all consecutive patients with PAP test performed at the Department of Clinical Cytology of the University Hospital Center Osijek from 2002 until the end of 2014. There was one inclusion criteria: subsequent hysterectomy or curettage within the six month after the PAP test, regardless of histological finding. From a total of 263 patients with previous PAP test and histologically proven endometrial cancer, endometrial cancer was cytologicaly diagnosed in 24.7% (including suspicious and positive findings), while 66.2% patients had normal cytological findings. The diagnostic value of PAP test in detection of endometrial cancer was statistically revealed with 25% sensitivity and 99% specificity. To determine false negative rate VCE samples were reviewed for patients with histologically proven endometrial cancer and negative VCE findings. There were a total of five negative results. In one case revision did not changed the original negative diagnosis, but benign endometrial cells, a lot of blood and inadequate cytohormonal status were found. In three out of four reviewed samples there were missed cells of endometrial adenocarcinoma. Review of remaining VCE sample upgraded the diagnosis from negative to suspicious for endometrial cancer. Proportion of error in the detection of endometrial cancer using cytological findings was 3.4% (true false negatives). Negative rate of the cytological findings in the detection of endometrial cancer was 66.2%. PAP test is not a suitable method for detection of endometrial carcinoma due to low sensitivity (25%). The main cause of negative findings in PAP test was lack of diagnostic cells in the sample.

摘要

子宫内膜癌是最常见的妇科癌症,但目前尚无经济上合理的筛查方法。尽管我们可以通过巴氏试验在样本中检测到子宫内膜细胞,但许多研究表明,巴氏试验对子宫内膜癌诊断的敏感性和阳性预测值较低。本研究的目的是确定巴氏试验对子宫内膜癌诊断的意义。通过统计参数分析敏感性和特异性。对经组织学证实为子宫内膜癌的患者的阴道、宫颈、宫颈管(VCE)涂片进行重新检查,以确定VCE样本中子宫内膜癌细胞假阴性结果的比例。研究组包括2002年至2014年底在奥西耶克大学医院中心临床细胞学系进行巴氏试验的所有连续患者。纳入标准为:巴氏试验后六个月内进行子宫切除或刮宫,无论组织学检查结果如何。在总共263例曾进行巴氏试验且经组织学证实为子宫内膜癌的患者中,24.7%(包括可疑和阳性结果)通过细胞学诊断为子宫内膜癌,而66.2%的患者细胞学检查结果正常。巴氏试验检测子宫内膜癌的诊断价值经统计显示敏感性为25%,特异性为99%。为确定假阴性率,对经组织学证实为子宫内膜癌且VCE检查结果为阴性的患者的VCE样本进行复查。共有五个阴性结果。其中一例复查未改变原阴性诊断,但发现良性子宫内膜细胞、大量血液和细胞激素状态不佳。在四分之三复查的样本中,遗漏了子宫内膜腺癌细胞。对其余VCE样本的复查将诊断从阴性升级为子宫内膜癌可疑。使用细胞学检查结果检测子宫内膜癌的错误比例为3.4%(真正的假阴性)。细胞学检查结果检测子宫内膜癌的阴性率为66.2%。由于敏感性低(25%),巴氏试验不是检测子宫内膜癌的合适方法。巴氏试验阴性结果的主要原因是样本中缺乏诊断性细胞。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验